IP Library Granted Patent US 11,291,652
Granted Patent B2
US 11,291,652 · App. 16/917,677 · Granted Apr 5, 2022

Glycopyrrolate salts

Inventors: John Allan Statler (Redwood City, CA); Anthony Adrian Shaw (North Vancouver, CA); Delphine Caroline Imbert (Cupertino, CA); Jennifer Leigh Nelson (Kokomo, IN); Patricia Andres (West Lafayette, IN); Lisa Lynn McQueen (West Lafayette, IN); Stephan Xander Mattheus Boerrigter (West Lafayette, IN); Jon Gordon Selbo (West Lafayette, IN); Mark Christopher Andres (West Lafayette, IN)
Assignee: JOURNEY MEDICAL CORPORATION
A61K31/40A61K9/0014A61K9/08A61K47/10A61K47/12A61K47/32A61K47/34C07D207/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,291,652
App. No.
16/917,677
Granted
Apr 5, 2022
Kind
B2
Abstract

Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.

Claims (22)

1. A method of making threo glycopyrrolate tosylate comprising:

a) treating racemic cyclopentylmandelic acid with racemic 1-methylpyrrolidin-3-ol and 1,1′ carbonyldiimidazole in a suitable solvent to form glycopyrrolate base;

b) treating the glycopyrrolate base in a suitable solvent with a resolving acid to form a salt of threo glycopyrrolate;

c) treating the salt of the threo glycopyrrolate salt with a suitable base in a suitable solvent to form a base of threo glycopyrrolate; and

d) treating the base of threo glycopyrrolate with methyl 4-methylbenzenesulfonate in a suitable solvent to form threo glycopyrrolate tosylate.

2. The method of claim 1 further comprising the step of treating the threo glycopyrrolate tosylate in water to form Form D glycopyrrolate tosylate monohydrate.

3. The method of claim 1 , wherein the resolving acid in step b) is 5-Nitroisophthalic acid.

4. The method of claim 1 , wherein the resulting solution in a) is heated.

5. The method of claim 1 , wherein the suitable solvent in step a) comprises an organic solvent.

6. The method of claim 5 , wherein the organic solvent is toluene.

7. The method of claim 1 , wherein the suitable solvent in step b) comprises an alcohol.

8. The method of claim 7 , wherein the alcohol is methanol.

9. The method of claim 1 , wherein the suitable solvent in step c) comprises a solution comprising water and an organic solvent.

10. The method of claim 9 , wherein the organic solvent is toluene.

11. The method of claim 1 , wherein the suitable solvent is step d) comprises an organic solvent.

12. The method of claim 11 , wherein the organic solvent is selected from acetone and ethyl acetate.

13. The method of claim 12 , wherein the organic solvent is acetone.

14. The method of claim 2 , wherein the treatment with water comprises crystallizing Form D glycopyrrolate tosylate monohydrate in water.

15. The method of claim 14 , wherein the crystallization is performed with seed crystals of Form D glycopyrrolate tosylate monohydrate.

16. The method of claim 15 further comprising drying the crystallized Form D glycopyrrolate tosylate monohydrate.

17. The method of claim 5 , 7 , 9 , or 11 , wherein the organic solvent of step a) is toluene;

the alcohol of step b) is methanol; the organic solvent of step c) is toluene; and the organic solvent of step d) is acetone.

Assignments (2)
SECURITY INTEREST Recorded Dec 28, 2023
From: JOURNEY MEDICAL CORPORATION; JG PHARMA, INC.
To: SWK FUNDING LLC
Reel/Frame 066157/0079 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2021
From: DERMIRA, INC.
To: JOURNEY MEDICAL CORPORATION
Reel/Frame 056829/0767 →